Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2013 | $255,775 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2013 | $147,484 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2013 | $36,899 | | tax credit/rebate |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2013 | $33,421 | | tax credit/rebate |
Supelco, Inc. | Merck KGaA (EMD) | Pennsylvania | state | 2013 | $25,992 | | tax credit/rebate |
Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Pennsylvania | state | 2013 | $14,203 | | tax credit/rebate |
Ventana USA | Roche | Pennsylvania | state | 2013 | $12,320 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica Inc. | Eli Lilly | Iowa | state | 2014 | $506,133 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2013 | $4,414,142 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $1,077,666 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2013 | $755,362 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2013 | $547,098 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2013 | $338,906 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2013 | $272,967 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $201,061 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2013 | $154,920 | | tax credit/rebate |
Pharmacia Corporation | Pfizer | North Carolina | state | 2013 | $145,378 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $115,708 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2013 | $108,155 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $85,010 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2013 | $57,596 | | tax credit/rebate |
Valeant Pharmaceuticals International | Bausch Health | North Carolina | state | 2013 | $47,287 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2013 | $42,180 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2013 | $37,544 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2013 | $31,549 | | tax credit/rebate |
Icagen, Inc. | Pfizer | North Carolina | state | 2013 | $29,917 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2013 | $19,136 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2013 | $17,655 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2013 | $13,505 | | tax credit/rebate |
Pozen, Inc. | Miravo Healthcare | North Carolina | state | 2013 | $13,254 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2013 | $8,044 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2013 | $7,359 | | tax credit/rebate |
Sprout Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $5,646 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2013 | $4,011 | | tax credit/rebate |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2013 | $2,237 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2013 | $2,120 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2013 | $1,816 | | tax credit/rebate |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2013 | $1,058 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2013 | $1,230,023 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $955,302 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $816,254 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2013 | $645,885 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $261,281 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2013 | $250,478 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2013 | $27,212 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $14,625 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $8,650 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2013 | $6,107 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2013 | $4,097,786 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $687,362 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $231,735 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2013 | $167,753 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $147,230 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $72,693 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2013 | $63,148 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2013 | $44,364 | | tax credit/rebate |
Eon Labs, Inc. | Novartis | North Carolina | state | 2013 | $43,359 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2013 | $29,864 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2013 | $7,529 | | tax credit/rebate |
Durata Therapeutics, Inc. | AbbVie | Connecticut | state | 2013 | $8,000 | | tax credit/rebate |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | Florida | state | 2014 | $2,779,200 | | tax credit/rebate |
Lupin, Inc. | Lupin Limited | Florida | state | 2014 | $252,000 | | tax credit/rebate |
Cambrex Charles City, Inc | Cambrex | Iowa | state | 2012 | $537,648 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2010 | $5,275,484 | | tax credit/rebate |
Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | Kentucky | state | 2015 | $2,500,000 | | tax credit/rebate |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2014 | $273,219 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2014 | $3,476,438 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2014 | $645,884 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2014 | $185,492 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $97,337 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2014 | $59,897 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2014 | $19,526 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2014 | $29,864 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $162,504 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2014 | $218,428 | | tax credit/rebate |
Biovail Americas Corporation and subsidiaries | Bausch Health | New Jersey | state | 2013 | $39,502,500 | | tax credit/rebate |
Sandoz Inc. | Sandoz Group | New Jersey | state | 2014 | $9,180,000 | | tax credit/rebate |
Zoetis, LLC | Zoetis | Nebraska | state | 2014 | undisclosed | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2015 | $6,700,000 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2015 | $9,000,000 | | tax credit/rebate |
Acorda Therapeutics | Acorda Therapeutics | New York | state | 2015 | $5,209,220 | | tax credit/rebate |
Par Pharmaceutical Companies, Inc. | Endo International | New York | state | 2015 | $2,500,000 | | tax credit/rebate |
Protein Sciences Corp | Sanofi | New York | state | 2015 | $2,000,000 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2015 | $10,200,000 | | tax credit/rebate |
Silarx Pharmaceuticals, Inc. | Lannett Co. | New York | state | 2015 | $952,757 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2014 | $253,035 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2014 | $143,193 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $126,863 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2014 | $117,680 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2014 | $57,885 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2014 | $13,840 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2014 | $11,365 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2014 | $8,340 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2014 | $5,969 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2014 | $5,583 | | tax credit/rebate |
Pozen, Inc. | Miravo Healthcare | North Carolina | state | 2014 | $5,426 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2014 | $1,644 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2014 | $6,118,950 | | tax credit/rebate |
GlaxoSmithKline, LLC (f/k/a SmithKline Beecham Corporation) | GlaxoSmithKline | Pennsylvania | state | 2014 | $3,353,317 | | tax credit/rebate |
Janssen Research & Development, LLC (f/k/a J&J Pharmaceutical Research & Development LLC) | Johnson & Johnson | Pennsylvania | state | 2014 | $2,207,905 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2014 | $1,144,884 | | tax credit/rebate |